EP3982960
Meðhöndlun á arfgengum ofsabjúgi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.6.2020EP published:
28.6.2023EP application number:
20734283.3
EP translation filed:
28.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
14.6.2040Expiry date:
14.6.2026Next due date:
30.6.2026
Title in English:
TREATMENTS OF HEREDITARY ANGIOEDEMALanguage of the patent:
English
Timeline
Today
15.6.2020EP application
28.6.2023EP Publication
28.8.2023Translation submitted
15.9.2023Registration published
14.6.2026Expires
Owner
Name:
Kalvista Pharmaceuticals LimitedAddress:
Porton Science Park Bybrook Road, Porton Down, Salisbury SP4 0BF Wiltshire, GB
Inventor
Name:
FEENER, Edward PaulAddress:
North Reading, Massachusetts 01864, US
Name:
MARSH, Sally LouiseAddress:
Salisbury, Wiltshire SP4 0BF, GB
Name:
MAETZEL, AndreasAddress:
Chapel Hill, North Carolina 27516, US
Name:
SMITH, Michael DavidAddress:
Salt Lake City, Utah 84109, US
Name:
YEA, Christopher MartynAddress:
Salisbury, Wiltshire SP4 0BF, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962861725 PDate:
14.6.2019Country:
US
Number:
201910116Date:
15.7.2019Country:
GB
Classification
Categories:
A61K 31/444, A61P 7/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.5.2024
Expires: 14.6.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 2.6.2025
Expires: 14.6.2026
Payer: Árnason Faktor ehf.